Page 29 - ஷார்துள் அமர்சந்த் மங்கல்தாஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Walmart s Flipkart is said to aim for IPO in fourth quarter

Walmart s Flipkart is said to aim for IPO in fourth quarter
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNeha singhSaroj panigrahiJpmorgan chase coGoldman sachs group incShardul amarchand mangaldas coKorea coupang incWalmart incBloomberg newsGoldman sachs groupTracxn technologiesFlipkart wholesaleShardul amarchand mangaldasபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்

Flipkart is said to aim for IPO in fourth quarter of 2021

Flipkart is said to aim for IPO in fourth quarter of 2021
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

ChrysCapital announces investment in Corona Remedies

ChrysCapital announces investment in Corona Remedies By IANS | Published on Mon, Apr 5 2021 20:57 IST | 9 Views CFMA sees poetic justice for MF investors through 6 FTMF shut funds case in SC.. Image Source: IANS News New Delhi, April 5 : ChrysCapital, one of the leading private equity funds in India, has announced its investment in Corona Remedies Private Limited (Corona), one of the country s fastest growing pharmaceutical companies, by acquiring a 27 per cent stake through an entirely secondary deal. Commenting on the investment, Kshitij Sheth, Director, ChrysCapital, said, ChrysCapital is very excited to partner with Corona in its growth journey. The domestic pharmaceutical market is a large, attractive and resilient market with a healthy outlook. Corona is among the fastest growing companies in the Indian pharmaceutical market with presence in exciting therapeutic areas including cardiology, diabetology and gynaecology. ChrysCapital believes Corona

New delhiAnkur mehtaIntas pharmaZydus cadilaNirav mehtaShardul amarchand mangaldasKshitij shethCorona remedies private limitedFounder directorCapital advisorsVertices partnersMankind pharmaEris lifesciencesTorrent pharmaIpca labsCuratio healthcare

Indian PE firm ChrysCapital picks 27% stake in Corona Remedies

Indian PE firm ChrysCapital picks 27% stake in Corona Remedies Photographer: Krisztian Bocsi/Bloomberg April 5, 2021 Indian homegrown private equity (PE) major ChrysCapital has picked up a 27% stake in Gujarat-based drug manufacturer Corona Remedies through a secondary transaction, according to a press statement issued jointly by the companies on Monday. While other financial details of the transaction were not disclosed, DealStreetAsia had reported on March 30 that ChrysCapital is close to investing $100 million in Corona Remedies. The report also mentioned that Malaysian PE firm Creador is exiting as part of the transaction. Creador had acquired a 20% stake in Corona Remedies for Rs 120 crore in 2016.

Ankur mehtaKirtibhai mehtaNirav mehtaShardul amarchand mangaldasKshitij shethCorona remediesCapital advisorsVertices partnersஅன்குர் மேத்தாகிர்த்திபைய் மேத்தாநீரவ் மேத்தாஷார்துள் அமர்சந்த் மங்கல்தாஸ்க்ஷித்ிஜ் உறைகொரோனா வைத்தியம்செங்குத்துகள் கூட்டாளர்கள்

Govt amends insolvency law; introduces pre-packaged resolution for MSMEs

Seeking to provide a quicker and value-maximising outcome for stressed MSMEs, the government has introduced a pre-packaged resolution process for such enterprises by amending the insolvency law. Now, Micro, Small and Medium Enterprises (MSMEs) can seek resolution for their stress through the pre-packaged process under the Insolvency and Bankruptcy Code (IBC). An ordinance was promulgated to amend the IBC on April 4. Many MSMEs have been impacted by the coronavirus pandemic and experts opined that the latest amendment, which comes less than two weeks after the suspension of certain IBC provisions ended, is a welcome move. The suspension wherein fresh insolvency proceedings were not allowed for a year starting from March 25, 2020 was implemented amid the coronavirus pandemic disrupting economic activities.

Rajiv chandakCyril amarchand mangaldasSoumitra majumdarNational company law tribunalJ sagar associatesPartner at shardul amarchand mangaldas coMedium enterprises msmesMedium enterprisesBankruptcy codeSwiss challengeShardul amarchand mangaldasDeloitte indiaIndian companiesInsolvency lawராஜீவ் சண்டக்சிரில் அமர்சந்த் மங்கல்தாஸ்